Raffa Wealth Management’s Biogen BIIB Stock Holding History

Raffa Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.3K	Buy	57 +4	+8%	+$765	﹤0.01%	382
2026 Q1	$9.72K	Buy	53 +2	+4%	+$369	﹤0.01%	400
2025 Q4	$8.97K	Buy	51 +16	+46%	+$2.61K	﹤0.01%	393
2025 Q3	$4.9K	Buy	35 +14	+67%	+$1.89K	﹤0.01%	491
2025 Q2	$2.64K	Hold	21	–	–	﹤0.01%	631
2025 Q1	$2.87K	Sell	21 -4	-16%	-$572	﹤0.01%	548
2024 Q4	$3.82K	Hold	25	–	–	﹤0.01%	504
2024 Q3	$4.85K	Hold	25	–	–	﹤0.01%	424
2024 Q2	$5.8K	Hold	25	–	–	﹤0.01%	522
2024 Q1	$5.39K	Sell	25 -6	-19%	-$1.41K	﹤0.01%	496
2023 Q4	$8.02K	Hold	31	–	–	﹤0.01%	328
2023 Q3	$7.97K	Hold	31	–	–	﹤0.01%	309
2023 Q2	$8.83K	Hold	31	–	–	﹤0.01%	300
2023 Q1	$8.62K	Hold	31	–	–	﹤0.01%	317
2022 Q4	$8.59K	Hold	31	–	–	﹤0.01%	305
2022 Q3	$8.28K	Hold	31	–	–	﹤0.01%	301
2022 Q2	$6.32K	Hold	31	–	–	﹤0.01%	340
2022 Q1	$6.53K	Hold	31	–	–	﹤0.01%	356
2021 Q4	$7.44K	Hold	31	–	–	﹤0.01%	348
2021 Q3	$8.77K	Hold	31	–	–	﹤0.01%	279
2021 Q2	$10.7K	Hold	31	–	–	﹤0.01%	257
2021 Q1	$8.67K	Buy	31 +5	+19%	+$1.35K	﹤0.01%	296
2020 Q4	$6.37K	Hold	26	–	–	﹤0.01%	317
2020 Q3	$7.38K	Buy	26 +4	+18%	+$1.12K	﹤0.01%	277
2020 Q2	$5.89K	Hold	22	–	–	﹤0.01%	289
2020 Q1	$6.96K	Buy	22 +6	+38%	+$1.82K	﹤0.01%	236
2019 Q4	$4.75K	Hold	16	–	–	﹤0.01%	277
2019 Q3	$3.73K	Buy	+16	New	+$3.73K	﹤0.01%	303
2019 Q2	–	Sell	-16	Closed	-$3.78K	–	814
2019 Q1	$3.78K	Hold	16	–	–	﹤0.01%	266
2018 Q4	$4.82K	Hold	16	–	–	﹤0.01%	245
2018 Q3	$5.65K	Hold	16	–	–	﹤0.01%	250
2018 Q2	$4.64K	Hold	16	–	–	﹤0.01%	253
2018 Q1	$4.38K	Buy	+16	New	+$4.97K	﹤0.01%	256
2017 Q1	–	Sell	-5	Closed	-$1.42K	–	434
2016 Q4	$1.42K	Hold	5	–	–	﹤0.01%	340
2016 Q3	$1.56K	Hold	5	–	–	﹤0.01%	315
2016 Q2	$1.21K	Hold	5	–	–	﹤0.01%	347
2016 Q1	$1.3K	Hold	5	–	–	﹤0.01%	337
2015 Q4	$1.53K	Hold	5	–	–	﹤0.01%	298
2015 Q3	$1.46K	Hold	5	–	–	﹤0.01%	315
2015 Q2	$2.02K	Hold	5	–	–	﹤0.01%	274
2015 Q1	$2.11K	Hold	5	–	–	﹤0.01%	261
2014 Q4	$1.7K	Hold	5	–	–	﹤0.01%	268
2014 Q3	$1.65K	Buy	+5	New	+$1.65K	﹤0.01%	273
2014 Q1	–	Sell	-5	Closed	-$1.7K	–	326
2013 Q4	$1.7K	Buy	+5	New	+$1.29K	﹤0.01%	268

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Raffa Wealth Management's BIIB Position: Q2 2026 in Review

Raffa Wealth Management increased its Biogen (BIIB) stake by 7.5% in Q2 2026, buying an estimated $765 and bringing the position to 57 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #382.

Raffa Wealth Management first reported a position in BIIB in Q4 2013 and has held it in 44 quarters since. 981 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Raffa Wealth Management held 57 shares of Biogen worth $12.3K as of Q2 2026.
Raffa Wealth Management bought 4 Biogen shares in Q2 2026, an estimated $765.
Biogen made up ﹤0.01% of Raffa Wealth Management's portfolio in Q2 2026, its #382 holding.
Raffa Wealth Management first reported a position in Biogen in Q4 2013 and has held it in 44 quarters since.
981 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.